TB-500 accelerates the broader repair ecosystem
Product Details Composition and Format Active Ingredient: Tirzepatide Concentration: 10mg per vial Package Size: 10 vials per pack Form: Lyophilized powder for reconstitution Purity: 99% (HPLC verified) Analytical Verification High-Performance Liquid Chromatography (HPLC) tested Mass Spectrometry (MS) confirmed Certificate of Analysis (COA) provided with each batch Third-party laboratory verification Intended Professional Use This GLP-1 receptor agonist peptide is intended for purposes in metabolic studies
Tuning an engine (Metabolic)
In one clinical trial in people with type 2 diabetes, the weight loss became noticeable as early as week five, with participants taking Zepbound having lost nearly 6 pounds (compared with only about 2 pounds for those taking a placebo)
Oversight ensures dosing adjustments are timely and effective
In the United States, it received initial FDA approval on May 13, 2022, to improve glycemic control in type 2 diabetes as an adjunct to diet and exercise for adults, later expanding to pediatric patients aged 10 years and older.[4] U.S